Beacon Financial Strategies Corp Bristol Myers Squibb CO Transaction History
Beacon Financial Strategies Corp
- $159 Billion
- Q2 2025
Shares
2 transactions
Others Institutions Holding BMY
# of Institutions
2,676Shares Held
1.64BCall Options Held
22.4MPut Options Held
25.4M-
Vanguard Group Inc Valley Forge, PA195MShares$8.86 Billion0.15% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.21 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY108MShares$4.91 Billion0.52% of portfolio
-
State Street Corp Boston, MA94.7MShares$4.31 Billion0.17% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA70.8MShares$3.22 Billion0.59% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $96.6B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...